Tortoise Acquisition Corp. Files for $225M SPAC IPO
by Kristi Marvin on 2019-02-06 at 10:02pm

Wednesday evening, we had a new SPAC IPO filing in the form of the $225 million Tortoise Acquisition Corp.  Tortoise is being led by Vincent Cubbage, as CEO, President and Chairman of the Board of Directors. Most recently, Mr. Cubbage was the former CEO of Lightfoot Capital Partners GP LLC, and is currently a Managing Director, Private Energy, of Tortoise Capital Advisors, L.L.C., since January 2019.

This is an interesting SPAC for a number of reasons, but first and foremost is the fact that Barclays is on the cover as a new entrant in the SPAC underwriting game.  Plus, Barclays decided to debut with Goldman Sachs and UBS as its joint bookrunners (however, Barclays is still left lead).  That’s a solid line-up of tier-1 banks, but will Barclays need to lean on Goldman and UBS as a SPAC newbie?  Remains to be seen…SPACs are harder than they look.

Regardless, this SPAC’s structure has a few bells and whistles to boot, but let’s start with the basics.  First off, this is a 100% in trust, 24 months deal, but with 1/2 warrant in its unit, not 1/3.  Plus, Tortoise has added the option of calling the warrants for shares at $10.00.  This feature is typically seen (so far) in tier-1 SPACs and means that while the company can call the warrants post-combination for cash or cashless exercise at $18.00, they can also call them for redemption for shares at $10.00 or greater.  The amount of shares an investor will receive in the call for shares scenario is based on a black scholes model that has calculated the fair market value based on the time and price at which they are called. We’ve discussed the merits of this term before and you can read about that here.

Additionally, you will also see the appearance of the Crescent Term once again and just like in the Deutsche Bank deals of  RMG and DiamondPeak, Tortoise is using a threshold of $9.20 before they will reset the warrant strike in the event of a PIPE done below $10.00 at combination.  The use of $9.20, rather than $9.50 (seen in Megalith, EdTechX, etc.) appears to be a way of distinguishing the tier-1 deals from the rest of the pack.  In the parlance of the sub-35 year old crowd, “you can’t sit with us”.

Lastly, Tortoise has added a forward purchase agreement for $150 million from Atlas Point Energy Infrastructure Fund, LLC (“Atlas Point Energy”), but there is an added twist.  Typically, a forward purchase agreement is done at $10.00 per unit. However, in Tortoise’s forward purchase, the SPAC team has the option of allowing Atlas Point Energy to purchase either units at $10.00 or just shares at $9.67 – the choice is at Tortoise’s discretion at the time of the business combination.  Generally, post-unit split of a SPAC IPO of this structure, $9.67 is where the share would trade anyway, but the optionality for management to decide which they would like Atlas to purchase is a nice feature.

All told, this is a pretty good structure and the 1/2 warrant feels appropriate and sell-able. Plus, the Crescent Term and $150 million Forward Purchase add a little gravy to this meal.  It’s all about the roadshow now and how the team performs.

Summary of terms below:

Tortoise terms 2-6-19

Barclays Capital Inc., Goldman Sachs & Co. LLC and UBS Securities LLC are joint book-running managers.
Vinson & Elkins L.L.P. and Skadden, Arps, Slate, Meagher & Flom LLP are issuer’s counsel and underwriter’s counsel, respectively.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved